{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2025,11,6]],"date-time":"2025-11-06T08:47:19Z","timestamp":1762418839504,"version":"build-2065373602"},"reference-count":27,"publisher":"Elsevier BV","issue":"6","license":[{"start":{"date-parts":[[2022,11,1]],"date-time":"2022-11-01T00:00:00Z","timestamp":1667260800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2022,11,1]],"date-time":"2022-11-01T00:00:00Z","timestamp":1667260800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"}],"content-domain":{"domain":["clinicalkey.com","clinicalkey.com.au","clinicalkey.es","clinicalkey.fr","clinicalkey.jp","elsevier.es","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Revista Espa\u00f1ola de Medicina Nuclear e Imagen Molecular (English Edition)"],"published-print":{"date-parts":[[2022,11]]},"DOI":"10.1016\/j.remnie.2021.09.009","type":"journal-article","created":{"date-parts":[[2022,2,28]],"date-time":"2022-02-28T07:59:07Z","timestamp":1646035147000},"page":"345-349","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":0,"title":["Indications and results of sentinel lymph node biopsy in breast cancer: Changes observed in 2018 compared to 2012"],"prefix":"10.1016","volume":"41","author":[{"given":"E.S.","family":"Merino San Mart\u00edn","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"L.","family":"Fr\u00edas Aldeguer","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"P.","family":"Ord\u00e1s \u00c1lvarez","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"L.","family":"Garc\u00eda Calvo","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"C.","family":"Escabias del Pozo","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"L.","family":"Dom\u00ednguez Gadea","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"C.","family":"Mart\u00ed \u00c1lvarez","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"A.","family":"Hern\u00e1ndez Guti\u00e9rrez","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"J.I.","family":"S\u00e1nchez-M\u00e9ndez","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"78","reference":[{"key":"10.1016\/j.remnie.2021.09.009_bib0005","doi-asserted-by":"crossref","first-page":"1233","DOI":"10.1056\/NEJMoa022152","article-title":"Twenty-year follow-up of a randomized trial comparing total mastectomy, lumpectomy, and lumpectomy plus irradiation for the treatment of invasive breast cancer","volume":"347","author":"Fisher","year":"2002","journal-title":"N Engl J Med."},{"key":"10.1016\/j.remnie.2021.09.009_bib0010","doi-asserted-by":"crossref","first-page":"511","DOI":"10.1007\/s10549-016-4012-8","article-title":"Breast-conserving therapy versus mastectomy in T1-2N2 stage breast cancer: a population-based study on 10-year overall, relative, and distant metastasis-free survival in 3071 patients","volume":"160","author":"van Maaren","year":"2016","journal-title":"Breast Cancer Res Treat."},{"key":"10.1016\/j.remnie.2021.09.009_bib0015","doi-asserted-by":"crossref","first-page":"3836","DOI":"10.1245\/s10434-015-4441-3","article-title":"Survival is better after breast conserving therapy than mastectomy for early stage breast cancer: a registry-based follow-up study of Norwegian women primary operated between 1998 and 2008","volume":"22","author":"Hartmann-Johnsen","year":"2015","journal-title":"Ann Surg Oncol."},{"key":"10.1016\/j.remnie.2021.09.009_bib0020","first-page":"604","article-title":"Lymphatic mapping and sentinel lymphadenectomy for breast cancer","volume":"220","author":"Chung","year":"1994","journal-title":"Ann Surg."},{"key":"10.1016\/j.remnie.2021.09.009_bib0025","doi-asserted-by":"crossref","first-page":"1818","DOI":"10.1001\/jama.1996.03540220042028","article-title":"Lymphatic mapping and sentinel node biopsy in the patient with breast cancer","volume":"276","author":"Albertini","year":"1996","journal-title":"J Am Med Assoc."},{"key":"10.1016\/j.remnie.2021.09.009_bib0030","doi-asserted-by":"crossref","first-page":"599","DOI":"10.1093\/jnci\/djj158","article-title":"Randomized multicenter trial of sentinel node biopsy versus standard axillary treatment in operable breast cancer: the ALMANAC trial","volume":"98","author":"Mansel","year":"2006","journal-title":"J Natl Cancer Inst."},{"key":"10.1016\/j.remnie.2021.09.009_bib0035","doi-asserted-by":"crossref","first-page":"927","DOI":"10.1016\/S1470-2045(10)70207-2","article-title":"Sentinel-lymph-node resection compared with conventional axillary-lymph-node dissection in clinically node-negative patients with breast cancer: overall survival findings from the NSABP B-32 randomised phase 3 trial David","volume":"11","author":"Krag","year":"2011","journal-title":"Lancet Oncol."},{"key":"10.1016\/j.remnie.2021.09.009_bib0040","doi-asserted-by":"crossref","first-page":"413","DOI":"10.1097\/SLA.0000000000001863","article-title":"Locoregional recurrence after sentinel lymph node dissection with or without axillary dissection in patients with sentinel lymph node metastases: long-term follow-up from the American College of Surgeons Oncology Group (Alliance) ACOSOG Z0011 randomized T","volume":"264","author":"Giuliano","year":"2016","journal-title":"Ann Surg."},{"key":"10.1016\/j.remnie.2021.09.009_bib0045","doi-asserted-by":"crossref","first-page":"293","DOI":"10.1016\/j.breast.2007.11.006","article-title":"Fragmentation of axillary fibrofatty tissue during dissection facilitates preservation of the intercostobrachial nerve and the lateral thoracic vein","volume":"17","author":"Ivanovic","year":"2008","journal-title":"Breast."},{"key":"10.1016\/j.remnie.2021.09.009_bib0050","first-page":"1358","article-title":"IBCSG 23-01 randomised controlled trial comparing axillary dissection versus no axillary dissection in patients with sentinel node micrometastases","volume":"76","author":"Galimberti","year":"2011","journal-title":"Lancet Oncol."},{"key":"10.1016\/j.remnie.2021.09.009_bib0055","doi-asserted-by":"crossref","first-page":"372","DOI":"10.1016\/S0002-9610(02)00939-X","article-title":"Tumor characteristics predictive of sentinel node metastases in 105 consecutive patients with invasive lobular carcinoma","volume":"184","author":"Grube","year":"2002","journal-title":"Am J Surg."},{"key":"10.1016\/j.remnie.2021.09.009_bib0060","doi-asserted-by":"crossref","first-page":"497","DOI":"10.1016\/j.crad.2010.11.015","article-title":"Staging primary breast cancer. Are there tumour pathological features that correlate with a false-negative axillary ultrasound?","volume":"66","author":"Johnson","year":"2011","journal-title":"Clin Radiol."},{"key":"10.1016\/j.remnie.2021.09.009_bib0065","first-page":"63","article-title":"Review of the role of the sentinel node biopsy in neoadjuvant chemotherapy in women with breast cancer and negative or positive axillary node at diagnosis","volume":"37","author":"Ruano P\u00e9rez","year":"2018","journal-title":"Rev Esp Med Nucl Imagen Mol."},{"key":"10.1016\/j.remnie.2021.09.009_bib0070","doi-asserted-by":"crossref","first-page":"1072","DOI":"10.1200\/JCO.2015.64.0094","article-title":"Improved axillary evaluation following neoadjuvant therapy for patientswith node-positive breast cancer using selective evaluation of clipped nodes: Implementation of targeted axillary dissection","volume":"34","author":"Caudle","year":"2016","journal-title":"J Clin Oncol."},{"key":"10.1016\/j.remnie.2021.09.009_bib0075","doi-asserted-by":"crossref","first-page":"221","DOI":"10.1159\/000351692","article-title":"13th St. Gallen international breast cancer conference 2013: primary therapy of early breast cancer evidence, controversies, consensus - opinion of a German team of experts (Zurich 2013)","volume":"8","author":"Untch","year":"2013","journal-title":"Breast Care."},{"key":"10.1016\/j.remnie.2021.09.009_bib0080","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1038\/s41598-021-81538-4","article-title":"Clinical implications of intrinsic molecular subtypes of breast cancer for sentinel node status","volume":"11","author":"Rossing","year":"2021","journal-title":"Sci Rep."},{"key":"10.1016\/j.remnie.2021.09.009_bib0085","doi-asserted-by":"crossref","first-page":"164","DOI":"10.1016\/S0140-6736(13)62422-8","article-title":"Pathological complete response and long-term clinical benefit in breast cancer: the CTNeoBC pooled analysis","volume":"384","author":"Cortazar","year":"2014","journal-title":"Lancet."},{"key":"10.1016\/j.remnie.2021.09.009_bib0090","doi-asserted-by":"crossref","first-page":"188","DOI":"10.1093\/jnci\/dji021","article-title":"Neoadjuvant versus adjuvant systemic treatment in breast cancer: a meta-analysis","volume":"97","author":"Mauri","year":"2005","journal-title":"J Natl Cancer Inst."},{"key":"10.1016\/j.remnie.2021.09.009_bib0095","doi-asserted-by":"crossref","first-page":"233","DOI":"10.1007\/s00432-009-0654-9","article-title":"Common and discriminative clinicopathological features between breast cancers with pathological complete response or progressive disease in response to neoadjuvant chemotherapy","volume":"136","author":"Osako","year":"2010","journal-title":"J Cancer Res Clin Oncol."},{"key":"10.1016\/j.remnie.2021.09.009_bib0100","first-page":"240","article-title":"Biopsia del ganglio centinela despu\u00e9s de la quimioterapia neoadyuvante en pacientes con c\u00e1ncer de mama operable y ganglios axilares positivos al diagn\u00f3stico","volume":"32","author":"Rebollo-Aguirre","year":"2013","journal-title":"Rev Esp Med Nucl Imagen Mol."},{"key":"10.1016\/j.remnie.2021.09.009_bib0105","doi-asserted-by":"crossref","first-page":"609","DOI":"10.1016\/S1470-2045(13)70166-9","article-title":"Sentinel-lymph-node biopsy in patients with breast cancer before and after neoadjuvant chemotherapy (SENTINA): a prospective, multicentre cohort study","volume":"14","author":"Kuehn","year":"2013","journal-title":"Lancet Oncol."},{"key":"10.1016\/j.remnie.2021.09.009_bib0110","doi-asserted-by":"crossref","first-page":"3144","DOI":"10.1245\/s10434-012-2531-z","article-title":"American College of Surgeons Oncology Group (ACOSOG) Z0011: impact on surgeon practice patterns","volume":"19","author":"Caudle","year":"2012","journal-title":"Ann Surg Oncol."},{"key":"10.1016\/j.remnie.2021.09.009_bib0115","doi-asserted-by":"crossref","first-page":"222","DOI":"10.1016\/j.ciresp.2019.01.010","article-title":"The decline of axillary lymph node dissection in breast cancer. Evolution of its indication over the last 20 years","volume":"97","author":"Garc\u00eda-Novoa","year":"2019","journal-title":"Cir Esp."},{"key":"10.1016\/j.remnie.2021.09.009_bib0120","doi-asserted-by":"crossref","first-page":"87","DOI":"10.1007\/s10549-013-2524-z","article-title":"Intraoperative molecular analysis of total tumor load in sentinel lymph node: a new predictor of axillary status in early breast cancer patients","volume":"139","author":"Peg","year":"2013","journal-title":"Breast Cancer Res Treat."},{"issue":"1","key":"10.1016\/j.remnie.2021.09.009_bib0125","article-title":"Consenso sobre la biopsia selectiva del ganglio centinela en el c\u00e1ncer de mama. Revisi\u00f3n 2013 de la Sociedad Espa\u00f1ola de Senolog\u00eda y Patolog\u00eda Mamaria","volume":"27","author":"Bernet","year":"2014","journal-title":"Rev Senol Patol Mamaria - J Breast Sci."},{"issue":"Supplement 5","key":"10.1016\/j.remnie.2021.09.009_bib0130","doi-asserted-by":"crossref","first-page":"v8","DOI":"10.1093\/annonc\/mdv298","article-title":"Primary breast cancer: ESMO Clinical Practice Guidelines for diagnosis, treatment and follow-up","volume":"26","author":"Senkus","year":"2015","journal-title":"Ann Oncol."},{"key":"10.1016\/j.remnie.2021.09.009_bib0135","doi-asserted-by":"crossref","first-page":"118","DOI":"10.6004\/jnccn.2019.0009","article-title":"Breast cancer, version 3.2018 featured updates to the NCCN guidelines","volume":"17","author":"Goetz","year":"2019","journal-title":"J Natl Compr Cancer Netw."}],"container-title":["Revista Espa\u00f1ola de Medicina Nuclear e Imagen Molecular (English Edition)"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S2253808922000064?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S2253808922000064?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,11,6]],"date-time":"2025-11-06T08:44:27Z","timestamp":1762418667000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S2253808922000064"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2022,11]]},"references-count":27,"journal-issue":{"issue":"6","published-print":{"date-parts":[[2022,11]]}},"alternative-id":["S2253808922000064"],"URL":"https:\/\/doi.org\/10.1016\/j.remnie.2021.09.009","relation":{},"ISSN":["2253-8089"],"issn-type":[{"type":"print","value":"2253-8089"}],"subject":[],"published":{"date-parts":[[2022,11]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Indications and results of sentinel lymph node biopsy in breast cancer: Changes observed in 2018 compared to 2012","name":"articletitle","label":"Article Title"},{"value":"Revista Espa\u00f1ola de Medicina Nuclear e Imagen Molecular (English Edition)","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.remnie.2021.09.009","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"https:\/\/doi.org\/10.1016\/j.remn.2021.09.013","name":"associatedlink","label":"CrossRef DOI link to the associated document"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2021 Sociedad Espa\u00f1ola de Medicina Nuclear e Imagen Molecular. Published by Elsevier Espa\u00f1a, S.L.U. All rights reserved.","name":"copyright","label":"Copyright"}]}}